Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
oncology
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
25 mars 2025 16h30 HE
|
Abpro Corporation
WOBURN, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and...
CORRECTION – Global Reach for Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
24 mars 2025 21h51 HE
|
Avance Clinical
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
Sermonix and Regor Announce Strategic Collaboration to Optimize Regor’s Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics
24 mars 2025 09h00 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio and CAMBRIDGE, Mass., March 24, 2025 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals, a privately held biopharmaceutical company developing innovative therapeutics to specifically treat...
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
24 mars 2025 08h00 HE
|
CG Oncology Inc.
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference
24 mars 2025 06h59 HE
|
Pasithea
Pasithea Therapeutics (KTTA) will present PAS-004 Phase 1 data at the 2025 CAGLA NeauxCancer Conference on March 28 in New Orleans.
Immuneering Corporation Announces Grant of Inducement Award
21 mars 2025 16h30 HE
|
Immuneering Corporation
Immuneering Corporation Announces Grant of Inducement Award
Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204 which will be unveiled at the 2025 NeauxCancer Conference
21 mars 2025 08h30 HE
|
Silexion Therapeutics Corp
Grand Cayman, Cayman Islands, March 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi)...
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
20 mars 2025 16h05 HE
|
Immuneering Corporation
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Teclison, Inc. to Participate in Upcoming Investor Conference
20 mars 2025 14h20 HE
|
Teclison
Teclison will present in the MedInvest Biotech + Pharma Investor Conference March 27, 2025 at 2:05pm ET
CURE Media Group and Oncology Nursing News® announce the 2025 Extraordinary Healer® award finalists and keynote speaker, Amy Robach
20 mars 2025 12h00 HE
|
CURE Media Group
CRANBURY, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- CURE Media Group and Oncology Nursing News® are pleased to announce the finalists for the 2025 Extraordinary Healer® award. This award honors...